$MRT Income Statement | Understand Stock

$MRT

$1.94 -$0.01 (0.51%) Close

$MRT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations and Comprehensive Loss

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 10 months to Dec 31, 2021
Revenue
Operating expenses:
Cost of revenues
General and administrative expenses
Selling and marketing expenses
Research and development expenses
Other expenses
Other income
Total operating expenses
Loss from operations
Fair value gain on derivative instrument
Financial income
Total other income
Financial expense
Loss before income tax expense
Net loss
Net loss attributable to stockholders
Class A ordinary shares
Class B ordinary shares
Total net loss attributable to stockholders

Other comprehensive loss
Foreign currency translation adjustments
Total comprehensive loss
Net loss per share
Weighted average shares used to compute basic and diluted net loss per share (in Shares)
Class A ordinary shares
Class B ordinary shares
Total weighted average shares used to compute basic and diluted net loss per share (in Shares)

Weighted average shares used to compute diluted net loss per share (in Shares)
Class A ordinary shares
Class B ordinary shares
Total weighted average shares used to compute diluted net loss per share (in Shares)

Net loss per common share – basic (in Dollars per share)
Class A ordinary shares
Class B ordinary shares
Total net loss per common share – basic (in Dollars per share)

Net loss per common share – diluted (in Dollars per share)
Class A ordinary shares
Class B ordinary shares
Total net loss per common share – diluted (in Dollars per share)

Comments